(1 - 14 von 17
)
Grünenthal GmbH presents tapentadol, a novel centrally...
www.ots.at
Tapentadol would be the first new molecular entity in the class of oral centrally acting analgesics to enter medical practice in over 25 years.
DIA Panellists to Face Rapid-fire Questions on Patient Engagement
www.prnewswire.co.uk
industry (Anton Hoos, Head of Medical Affairs, Amgen GmbH, ...
Patient engagement was a highlight of #DIA2017
medcitynews.com
— Anton Hoos, chief of medical for Amgen in Europe, agreed. Organizations across the board need to move together to involve patients in drug ... ›
What do stakeholders expect from patient engagement - Cvent
custom.cvent.com
2018 · Zitiert von: 19 — Executive Director4 | Anton Hoos MD, Head of Medical5 | Marc Boutin JD, Chief. Executive6 | Jan Geissler Dipl-Kfm, Futures Group Chair › files › Event
sortiert nach Relevanz / Datum